查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太立體定位神經導航系統市場：分析與預測（2025-2035）
市場調查報告書
商品編碼
1781118

亞太立體定位神經導航系統市場：分析與預測（2025-2035）

Asia-Pacific Stereotactic Neuro-Navigation System Market: Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 54 Pages | 商品交期: 1-5個工作天內

價格

亞太地區立體定位神經導航系統市場規模預計將從2024年的1.707億美元成長到2035年的7.022億美元，預測期內的年複合成長率為 14.05%。

由於神經系統疾病發生率的不斷上升，以及導航輔助手術相較於傳統手術的明顯優勢，立體定位神經導航系統（SVR）市場在亞太地區迅速擴張。人工智慧、機器學習和擴增實境（AR）等新技術的採用，擴大這些系統的臨床應用，同時也提高了手術的安全性和準確性。尤其是亞太地區人口老化，以及由此導致的與老齡化相關的神經系統疾病的增多，推動向微創手術的轉變，進一步加速對高精度導航系統的需求。

主要市場統計資料
預測期 2025-2035
2025年評估 1.887億美元
2035年預測 7.022億美元
年複合成長率 14.05%

然而，仍存在一些挑戰。高昂的初始成本和維護成本、難以與醫院現有的IT和影像基礎設施整合以及潛在的術中問題，都可能阻礙其廣泛應用，尤其是在資源有限的醫療環境中。儘管如此，中國、印度和日本等國家有利的監管改革、導航技術在脊椎和顱底手術等相關領域的廣泛應用以及進一步的技術創新預計將推動其持續成長。隨著該地區醫療基礎設施的成熟和發展，立體定位神經導航市場預計將持續成長。

由於帕金森氏症、癲癇和腦腫瘤等神經系統疾病的發生率不斷上升，市場迅速擴張。這些疾病迫切需要先進的影像導引手術解決方案，以改善臨床療效、安全性和準確性。立體定位神經導航系統正被醫院和專科醫療中心廣泛採用，用於實現微創手術並支持術中決策。

此外，機器學習、擴增實境和人工智慧（AI）等技術進步進一步擴展導航平台的功能。這些技術能夠實現即時可視化、精細的術前規劃並降低併發症風險，顯著提高手術品質。此外，微創神經外科技術的興起，帶來了住院時間縮短、復健速度加快等優勢，也進一步加速了此技術的普及。

由於醫療支出不斷成長、人們對先進手術設備的認知度不斷提高以及醫療基礎設施不斷發展，中國、印度、日本和韓國等國家推動該地區的市場擴張。然而，設備成本高、專業人才匱乏以及整合複雜等挑戰依然存在，尤其是在開發中國家。儘管如此，由於持續的研發、法規環境的改善以及臨床應用的不斷擴展，預計亞太地區的市場成長仍將持續。

市場區隔:

細分1：依地區

  • 亞太地區
    • 日本
    • 中國
    • 其他

本報告調查了亞太地區立體定位神經導航系統市場，並總結了主要趨勢、市場影響因素分析、法律制度、技術和專利分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

範圍和定義

第1章 市場：產業展望

  • 市場趨勢
    • 利用協同效應效應實現業務組合多元化
  • 贖回情景
  • 監管狀況/合規性
    • 日本
    • 中國
  • 供應鏈分析
  • 定價分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機會

第2章 立體定位神經導航系統市場（依地區）

  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 市場問題
    • 日本
    • 中國
    • 其他

第3章 市場：競爭基準化分析與公司概況

  • 關鍵策略和發展
  • 產品基準
  • 公司簡介
    • SaphireX Surgicals
    • SURGLASSES Inc.
    • HRS Navigation

第4章 調查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Stereotactic Neuro-Navigation System Market

The Asia-Pacific stereotactic neuro-navigation system market is projected to reach $702.2 million by 2035 from $170.7 million in 2024, growing at a CAGR of 14.05% during the forecast period 2025-2035. Strong market expansion for stereotactic neuro-navigation systems is being driven in the APAC region by the increasing frequency of neurological illnesses as well as the obvious benefits of navigation-assisted operations over traditional surgery. New technologies like artificial intelligence, machine learning, and augmented reality are expanding the clinical use of these systems while improving surgical safety and accuracy. The demand for high-accuracy navigation systems is being further accelerated by the regional shift towards minimally invasive operations, particularly as age-related neurological diseases increase due to ageing populations throughout APAC.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$188.7 Million
2035 Forecast$702.2 Million
CAGR14.05%

However, a number of obstacles persist. Wider use may be hampered, especially in settings with limited resources, by high acquisition and maintenance costs, challenges integrating with the hospital's current IT and imaging infrastructure, and possible intraoperative issues. Notwithstanding these obstacles, growth is anticipated to be sustained by further innovation, favourable regulatory changes in nations like China, India, and Japan, as well as the growing use of neuro-navigation in related specialities like spinal and skull base surgery. The stereotactic neuro-navigation market is expected to continue growing as healthcare infrastructure in both established and developing APAC markets improves.

Market Introduction

The market for APAC stereotactic neuro-navigation systems is expanding quickly due to the increased prevalence of neurological conditions such Parkinson's disease, epilepsy, and brain tumours. Advanced, image-guided surgical solutions that provide improved clinical results, safety, and precision are in high demand due to these diseases. Because they facilitate minimally invasive operations and enhance intraoperative decision-making, stereotactic neuro-navigation systems are becoming more and more popular in the region's hospitals and speciality centres.

The possibilities of neuro-navigation platforms are being further transformed by technological developments, such as the incorporation of machine learning, augmented reality, and artificial intelligence. Real-time visualisation, better surgical planning, and lower complication rates are made possible by these advancements. Adoption is also being accelerated by the move towards minimally invasive neurosurgery methods, which lead to shorter hospital stays and quicker recovery times.

Due to rising healthcare spending, rising awareness of sophisticated surgical instruments, and developing medical infrastructure, nations like China, India, Japan, and South Korea are spearheading the regional expansion. But issues like expensive equipment, a lack of expertise, and integration complexity still exist, especially in developing nations. Notwithstanding these obstacles, it is anticipated that continued research and development, advantageous regulatory changes, and expanded clinical uses will maintain the market's pace throughout Asia-Pacific.

Market Segmentation:

Segmentation 1: by Region

  • Asia-Pacific
    • Japan
    • China
    • Rest-of-Asia-Pacific

APAC Stereotactic Neuro-Navigation System Market Trends, Drivers and Challenges

Market Trends

  • The APAC region is the fastest-growing market for stereotactic neuro-navigation systems, with a strong projected CAGR through 2030.
  • Optical navigation systems are emerging as the leading technology segment due to their precision and ease of integration.
  • China is the leading contributor to market growth within the region, supported by rapid healthcare advancements.
  • Increasing clinical preference for image-guided neurosurgery is driving demand across both public and private healthcare institutions.
  • Growing adoption of hybrid navigation platforms combining stereotactic accuracy with advanced imaging tools.

Key Drivers

  • Rising incidence of neurological disorders such as brain tumors, epilepsy, and Parkinson's disease is fueling demand for advanced surgical technologies.
  • Increased use of navigation-assisted minimally invasive procedures for improved accuracy and faster recovery.
  • Advancements in AI, machine learning, and AR/VR are enhancing surgical planning and intraoperative precision.
  • Healthcare infrastructure development in emerging economies is enabling broader access to neuro-navigation systems.
  • Expanding government support and improving reimbursement scenarios in selected markets are encouraging adoption.

Major Challenges

  • High capital investment and ongoing maintenance costs limit accessibility for smaller hospitals and rural facilities.
  • Integration with existing hospital systems can be complex, requiring dedicated IT resources and system customization.
  • Shortage of trained neurosurgeons and technical staff poses barriers to widespread system adoption.
  • Diverse regulatory environments across APAC countries delay market entry and device approvals.
  • Concerns around data privacy and cybersecurity due to increased connectivity in AI-enabled systems.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Saphirex Surgicals
  • SURGLASSES Inc.
  • HRS Navigation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
  • 1.2 Reimbursement Scenario
  • 1.3 Regulatory Landscape/Compliance
    • 1.3.1 Japan
    • 1.3.2 China
  • 1.4 Supply Chain Analysis
  • 1.5 Pricing Analysis
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Prevalence of Neurological Disorders
      • 1.6.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complications Associated with the Use of Navigation Systems
      • 1.6.2.2 High Cost of Acquisition
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

  • 2.1 Asia Pacific
    • 2.1.1 Regional Overview
    • 2.1.2 Driving Factors for Market Growth
    • 2.1.3 Factors Challenging the Market
    • 2.1.4 Japan
    • 2.1.5 China
    • 2.1.6 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Key Strategies and Development
  • 3.2 Product Benchmarking
  • 3.3 Company Profiles
    • 3.3.1 SaphireX Surgicals
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personal
      • 3.3.1.6 Analyst View
    • 3.3.2 SURGLASSES Inc.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personal
      • 3.3.2.6 Analyst View
    • 3.3.3 HRS Navigation
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personal
      • 3.3.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Stereotactic Neuro-Navigation System Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 3: NMPA Classification
  • Figure 4: Supply Chain and Risks within the Supply Chain
  • Figure 5: Prevalence of Parkinson's Disease (by Region), 2016-2021
  • Figure 6: Increasing Incidence of CNS Brain Tumor Cases (by Region), 2022, 2025, 2035, and 2045
  • Figure 7: Increasing Aging Population Globally, Million, 2020-2023
  • Figure 8: Asia Pacific Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 9: Asia Pacific Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 10: Asia Pacific Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 11: Incidences of Neurological Disorders in Japan, Million, 2018-2021
  • Figure 12: Japan Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 13: Incidences of Neurological Disorders in China, Million, 2018-2021
  • Figure 14: China Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 15: Incidences of Neurological Disorders in Rest-of-Asia-Pacific, Million, 2018-2021
  • Figure 16: Rest-of-Asia-Pacific Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 17: Data Triangulation
  • Figure 18: Top-Down and Bottom-Up Approach
  • Figure 19: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Some of the Key Developments
  • Table 3: CPT Coding
  • Table 4: Inpatient Reimbursement
  • Table 5: Medical Devices Classification Medical Devices in Japan
  • Table 6: Price of Stereotactic Neuro-Navigation System
  • Table 7: Drivers, Restraints, and Opportunities: Current and Future Impact Assessment
  • Table 8: Comparison between Various Navigation-Assisted Surgeries Over Conventional Surgeries
  • Table 9: Sources of Error in Navigated Surgery
  • Table 10: Cost of Acquisition of Key Neuro-Navigation Systems
  • Table 11: Stereotactic Neuro-Navigation System Market (by Region), $Million, 2023-2035
  • Table 12: Japan Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 13: China Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 14: Rest-of-Asia-Pacific Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 15: Some of the Strategies and Development, January 2017-May 2025
  • Table 16: Stereotactic Neuro-Navigation System Market, Product Benchmarking (by Product)